Letter to the Editor January 21, 2016

Long-Term Treatment of Clozapine-Induced Leukopenia With Lithium: Fast-Onset Agranulocytosis Following Lithium Discontinuation

; ;

Prim Care Companion CNS Disord 2016;18(1):doi:10.4088/PCC.15l01841

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

To the Editor: The atypical antipsychotic clozapine is the most effective medication for treatment-resistant schizophrenia and schizoaffective disorder, improving psychopathology and quality of life; however, its use is limited by the risk of neutropenia (2.7%) and agranulocytosis (0.9%). In France, after initiation of clozapine, blood monitoring must occur on a weekly basis for the first 4 months, after which patients undergo monthly monitoring.

Lithium carbonate is known to increase the white blood cell (WBC) count by a mechanism that is still unclear but that may involve demargination, stimulation of granulocyte-macrophage colony-stimulating factor, and stimulation of cytokines.